TY - JOUR
T1 - Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam
AU - Bauer, Lance O.
AU - Gross, Jeffrey B.
AU - Meyer, Roger E.
AU - Greenblatt, David J.
N1 - Funding Information:
Acknowledgements This research was supported in part by NIAAA
Funding Information:
grant P50-AA03510 and NIH-GCRC Grant M01-RR06192. The assistance of Daniel Radecki, Bertha Robbins, RN and Drs. Bart Laurijssens and Laurence Schweitzer is greatly appreciated.
PY - 1997
Y1 - 1997
N2 - The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.
AB - The aim of the present investigation was to examine benzodiazepine sensitivity in abstinent alcoholics. For this purpose, two escalating doses of the benzodiazepine midazolam were IV administered to nine alcohol-dependent patients after 2-3 weeks of abstinence and 12 healthy, non-alcoholic volunteers. A variety of dependent measures were examined, including the power spectrum of the resting electroencephalogram (EEG) and evoked EEG responses, saccadic eye movements, self-reported sedation, and vigilance task performance. Analyses revealed a significant association between plasma midazolam levels and changes in EEG beta power, pattern shift visual evoked potential amplitude, heart rate, and saccade amplitude and velocity. The patient and control groups differed significantly in the onset latencies of their saccadic eye movements, and marginally in EEG beta power, both before and after midazolam. However, no differences were detected between the groups in the dose of midazolam required to produce sedation or in midazolam's neurophysiological effects.
UR - https://www.scopus.com/pages/publications/0030756287
UR - https://www.scopus.com/pages/publications/0030756287#tab=citedBy
U2 - 10.1007/s002130050404
DO - 10.1007/s002130050404
M3 - Article
C2 - 9361336
AN - SCOPUS:0030756287
SN - 0033-3158
VL - 133
SP - 293
EP - 299
JO - Psychopharmacology
JF - Psychopharmacology
IS - 3
ER -